PSYCHOMOTOR RETARDATION, ANOREXIA, WEIGHT-LOSS, SLEEP DISTURBANCES, AND LOSS OF ENERGY - PSYCHOPATHOLOGICAL CORRELATES OF HYPERHAPTOGLOBINEMIA DURING MAJOR DEPRESSION

被引:65
作者
MAES, M
MELTZER, HY
SCHARPE, S
COOREMAN, W
UYTTENBROECK, W
SUY, E
VANDERVORST, C
CALABRESE, J
RAUS, J
COSYNS, P
机构
[1] UNIV HOSP ANTWERPEN, DEPT PSYCHIAT, MUNSTERBILZEN, BELGIUM
[2] PSYCHIAT CTR WEYBURN, MUNSTERBILZEN, BELGIUM
[3] UNIV DIEPENBEEK, DR WILLEMS INST, DIEPENBEEK, BELGIUM
[4] UNIV ANTWERP, DEPT MED BIOCHEM, ANTWERP, BELGIUM
关键词
AFFECTIVE DISORDER; HAPTOGLOBIN; INFLAMMATION; PSYCHONEUROIMMUNOLOGY; SOMATIC SYMPTOMS;
D O I
10.1016/0165-1781(93)90081-Q
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Recently, we have established that major depression is characterized by hyperhaptoglobinemia, which may be regarded as an index of an ''acute'' phase response in that illness. The present study investigates the psychopathological correlates of increased plasma concentrations of haptoglobin (Hp) in major depression. To this end, the authors studied the Hp levels in relation to depressive items of the Structured Clinical Interview for DSM-III(SCID) and the Hamilton Rating Scale for Depression (HRSD) in 90 depressed subjects. There was a significant positive relationship between the SCID symptoms anorexia/weight loss, sleep, and psychomotor disorders and Hp plasma concentrations. Hp plasma levels were significantly and positively correlated with overall severity of illness (HRSD). The HRSD symptom correlates of higher Hp levels were loss of interest, middle insomnia, and psychomotor retardation. Up to 31.4% of the variance in Hp plasma values could be explained by psychomotor disorders, anorexia, weight loss, middle insomnia, and less diurnal variation of mood. It is suggested that hyperhaptoglobinemia, as an index of an ''acute'' phase response in major depression, is related to the somatic dimension of depressive illness.
引用
收藏
页码:229 / 241
页数:13
相关论文
共 58 条
[11]  
DEBERDT R, 1976, BIOL PSYCHIAT, V11, P69
[12]   REDUCTION OF EXPLORATORY-BEHAVIOR BY INTRAPERITONEAL INJECTION OF INTERLEUKIN-1 INVOLVES BRAIN CORTICOTROPIN-RELEASING FACTOR [J].
DUNN, AJ ;
ANTOON, M ;
CHAPMAN, Y .
BRAIN RESEARCH BULLETIN, 1991, 26 (04) :539-542
[13]  
DURUM SK, 1989, FUNDAMENTAL IMMUNOLO, P639
[14]   AUTOANTIBODIES IN AFFECTIVE-DISORDERS [J].
GASTPAR, M ;
MULLER, W .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1981, 5 (01) :91-97
[15]   INTERLEUKIN-1 RECEPTOR BLOCKADE ATTENUATES THE HOST INFLAMMATORY RESPONSE [J].
GERSHENWALD, JE ;
FONG, Y ;
FAHEY, TJ ;
CALVANO, SE ;
CHIZZONITE, R ;
KILIAN, PL ;
LOWRY, SF ;
MOLDAWER, LL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :4966-4970
[16]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[17]   CHRONIC FATIGUE SYNDROME - A WORKING CASE DEFINITION [J].
HOLMES, GP ;
KAPLAN, JE ;
GANTZ, NM ;
KOMAROFF, AL ;
SCHONBERGER, LB ;
STRAUS, SE ;
JONES, JF ;
DUBOIS, RE ;
CUNNINGHAMRUNDLES, C ;
PAHWA, S ;
TOSATO, G ;
ZEGANS, LS ;
PURTILO, DT ;
BROWN, N ;
SCHOOLEY, RT ;
BRUS, I .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (03) :387-389
[18]  
IMBODEN J, 1961, ARCH INTERN MED, V108, P115
[19]  
IRWIN M, 1990, ARCH GEN PSYCHIAT, V47, P713
[20]   REDUCTION OF IMMUNE FUNCTION IN LIFE STRESS AND DEPRESSION [J].
IRWIN, M ;
PATTERSON, T ;
SMITH, TL ;
CALDWELL, C ;
BROWN, SA ;
GILLIN, JC ;
GRANT, I .
BIOLOGICAL PSYCHIATRY, 1990, 27 (01) :22-30